Clinical efficacy of Azithromycin for COVID-19 management: A systematic meta-analysis of meta-analyses.

ABSTRACT:

Background

Azithromycin has been adopted as a component of the COVID-19 management protocol throughout the global healthcare settings but with a questionable if not downright unsubstantiated evidence base.

Objectives

In order to amalgamate and critically appraise the conflicting evidence around the clinical efficacy of Azithromycin (AZO) vis a vis COVID-19 management outcomes, a meta-analysis of meta-analyses was carried out to establish an evidence-based holistic status of AZO vis a vis its efficacy as a component-in-use of the COVID-19 management protocol.

Methods

A comprehensive systematic search was carried out through PubMed/Medline, Cochrane and Epistemonikos with a subsequent appraisal of abstracts and full-texts, as required. The Quality of Reporting of Meta-a

SUBMITTER: Yousafzai ADK 

PROVIDER: S-EPMC10017380 | biostudies-literature | 2023 Jul-Aug

REPOSITORIES: biostudies-literature